IL6 and COVID-19: One meta-analysis of mean IL-6 concentrations demonstrated 2.9-fold higher levels in patients with complicated COVID-19 compared with those with non-complicated disease (74), and another meta-analysis also reported the relation between IL-6 levels and severe condition (75), indicating that IL-6 was a good indicator of poor prognosis in COVID-19 (74).